Trastuzumab: A Cardiologist’s Perspective

Marc André Côté

doi:10.3747/co.v15i3.300

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Editorial

1 June 2008

Trastuzumab: A Cardiologist’s Perspective

Ctr. Malad Sein Deschenes Fabia, University Laval, CHAUQ, Quebec City, PQ, Canada

Curr. Oncol.2008, 15(3), 162-163;https://doi.org/10.3747/co.v15i3.300

Version Notes

Order Reprints

Abstract

A review of the randomized clinical trials of adjuvant trastuzumab in human epidermal growth factor receptor (HER2)—positive breast cancer demonstrates the great benefit of this monoclonal antibody whose potential cardiotoxicity is a fascinating problem for the cardiologist ¹. [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

The 3rd Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake

Contemporary Management of Stage I Testicular Seminoma: A Survey of Canadian Radiation Oncologists